Healthcare

Anumana Appoints Harry S. Palmin as CFO

CAMBRIDGE, Mass.--(BUSINESS WIRE)--#AI--Anumana, a leading AI-driven health technology company and portfolio company of nference, today announced the appointment of Harry…

8 months ago

PaceMate Names JR Finkelmeier as Chief Commercial Officer

Former Philips Executive Joins to Accelerate Commercial Strategy and Market GrowthSARASOTA, Fla.--(BUSINESS WIRE)--PaceMate®, a market-leading cardiac remote monitoring and cardiac…

8 months ago

PaceMate Names JR Finkelmeier as Chief Commercial Officer

Former Philips Executive Joins to Accelerate Commercial Strategy and Market GrowthSARASOTA, Fla.--(BUSINESS WIRE)--PaceMate®, a market-leading cardiac remote monitoring and cardiac…

8 months ago

Gilead Sciences: Native Health Navigator Program Connects Tribes to Cancer Care

NORTHAMPTON, MA / ACCESSWIRE / May 14, 2024 / Olivia Sloan was pursuing a career in health policy and research…

8 months ago

OSF HealthCare Joins MediLedger Network to Enhance Pricing Accuracy and Contract Management

PEORIA, IL / ACCESSWIRE / May 14, 2024 / OSF HealthCare, a health system in Illinois and Michigan, has joined…

8 months ago

Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference

SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused…

8 months ago

Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facility from Sixth Street

Apellis received $375 million in funding at close, with ability to access an additional $100 millionMajority of initial proceeds used…

8 months ago

Daré Bioscience Reports First Quarter 2024 Financial Results and Provides Company Update

Conference Call and Webcast Today at 4:30 p.m. ETDevelopment Program Highlights and Anticipated 2024 Milestones Ovaprene® hormone-free monthly intravaginal contraceptive…

8 months ago

Reviva Reports First Quarter 2024 Financial Results and Recent Business Highlights

– Gained alignment with U.S. Food and Drug Administration (FDA) on brilaroxazine clinical trials for New Drug Application (NDA) submission…

8 months ago

HealthEquity Closes Acquisition of BenefitWallet HSA Portfolio

Welcomes clients and members to its best-in-class platformDRAPER, Utah, May 14, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (Nasdaq: HQY) ("HealthEquity"),…

8 months ago